• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未分类的出血性疾病:氨甲环酸和/或去氨加压素止血挑战的结果

Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and/or desmopressin.

作者信息

Obaji S, Alikhan R, Rayment R, Carter P, Macartney N, Collins P

机构信息

Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK.

Arthur Bloom Haemophilia Centre, University Hospital of Wales, Cardiff, UK.

出版信息

Haemophilia. 2016 Mar;22(2):285-291. doi: 10.1111/hae.12811. Epub 2015 Sep 30.

DOI:10.1111/hae.12811
PMID:26422253
Abstract

INTRODUCTION

In a minority of patients with a significant bleeding history no cause is found despite extensive testing and we diagnose such cases as unclassified bleeding disorders (UBD). UBDs may have diverse underlying causes and currently no standard management strategy exists in the event of a haemorrhage or to cover surgery.

AIM

To document the clinical characteristics and response to treatment of UBDs.

METHODS

We performed a retrospective chart review of all patients with UBDs who had an invasive procedure at our centre between 1998 and 2014.

RESULTS

The commonest symptoms were menorrhagia (89%) and bleeding at the time of surgery (88%) or dental extraction (85%). A total of 33 patients underwent 78 minor and major haemostatic challenges. Haemostatic cover was provided in 28 procedures with tranexamic acid alone, two with desmopressin and 45 with both agents in combination. A successful haemostatic outcome was observed in 70/78 (90%) cases. No patient required additional surgical intervention to achieve haemostasis, but one patient required a platelet transfusion to control postoperative bleeding.

CONCLUSIONS

This is the first study to report on the investigation and treatment of UBD. Future studies are needed to further our understanding of the bleeding phenotype and identify any underlying causes.

摘要

引言

在少数有明显出血史的患者中,尽管进行了广泛检查仍未发现病因,我们将此类病例诊断为未分类出血性疾病(UBD)。UBD可能有多种潜在病因,目前在出血或手术时尚无标准的管理策略。

目的

记录UBD的临床特征及治疗反应。

方法

我们对1998年至2014年间在本中心接受侵入性操作的所有UBD患者进行了回顾性病历审查。

结果

最常见的症状是月经过多(89%)以及手术时出血(88%)或拔牙时出血(85%)。共有33例患者接受了78次轻微和重大止血挑战。28例手术仅使用氨甲环酸进行止血覆盖,2例使用去氨加压素,45例两者联合使用。78例中有70例(90%)止血成功。没有患者需要额外的手术干预来实现止血,但有1例患者需要输注血小板来控制术后出血。

结论

这是第一项报道UBD调查和治疗的研究。需要未来的研究来进一步了解出血表型并确定任何潜在病因。

相似文献

1
Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and/or desmopressin.未分类的出血性疾病:氨甲环酸和/或去氨加压素止血挑战的结果
Haemophilia. 2016 Mar;22(2):285-291. doi: 10.1111/hae.12811. Epub 2015 Sep 30.
2
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies.未分类出血性疾病患者的手术、月经过多和分娩管理:队列研究的系统评价。
Blood Coagul Fibrinolysis. 2021 Sep 1;32(6):366-372. doi: 10.1097/MBC.0000000000001045.
3
Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment.对一大群未分类出血性疾病患者的特征进行描述;临床特征、止血挑战的处理以及使用全球止血评估,并提出诊断和治疗建议。
Int J Lab Hematol. 2020 Apr;42(2):116-125. doi: 10.1111/ijlh.13124. Epub 2019 Nov 20.
4
Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors' Organisation centers for patients with unclassified bleeding disorders.英国血友病中心医生组织中心对未分类出血性疾病患者的当前实践和登记模式。
J Thromb Haemost. 2021 Nov;19(11):2738-2743. doi: 10.1111/jth.15492. Epub 2021 Aug 25.
5
Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin.遗传性出血性疾病女性月经过多的管理:一般原则及去氨加压素的应用
Haemophilia. 2008 Jan;14 Suppl 1:21-30. doi: 10.1111/j.1365-2516.2007.01611.x.
6
Ten-year study of postoperative complications following dental extractions in patients with inherited bleeding disorders.对遗传性出血性疾病患者拔牙术后并发症的十年研究。
Int J Oral Maxillofac Surg. 2017 Sep;46(9):1147-1150. doi: 10.1016/j.ijom.2017.04.016. Epub 2017 May 9.
7
Post-procedural bleeding rate and haemostatic treatment use for dental procedures before and after the implementation of a standardized protocol for people with inherited bleeding disorders.治疗后出血率和止血治疗在遗传性出血性疾病患者标准化方案实施前后用于牙科操作。
Haemophilia. 2022 Sep;28(5):806-813. doi: 10.1111/hae.14609. Epub 2022 Jun 25.
8
[Use of desmopressin in children with inherited platelet dysfunctions undergoing adenotonsillar procedures].[去氨加压素在接受腺扁桃体手术的遗传性血小板功能障碍儿童中的应用]
Acta Otorrinolaringol Esp. 2012 Mar-Apr;63(2):115-9. doi: 10.1016/j.otorri.2011.09.007. Epub 2011 Dec 6.
9
TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial.泰科速手术贴片与传统止血毡在心血管手术中控制出血的比较:一项随机对照试验。
Eur J Cardiothorac Surg. 2009 Oct;36(4):708-14. doi: 10.1016/j.ejcts.2009.04.057.
10
Peripartum Haemorrhage: Haemostatic Aspects of the New German PPH Guideline.围产期出血:德国新围产期出血指南的止血要点
Transfus Med Hemother. 2018 Apr;45(2):127-135. doi: 10.1159/000478106. Epub 2017 Nov 15.

引用本文的文献

1
[Bleeding disorders of unknown cause : Definition, diagnostics and management in the perioperative and periprocedural setting].[不明原因出血性疾病:围手术期和围操作期的定义、诊断与管理]
Anaesthesiologie. 2025 Aug;74(8):540-550. doi: 10.1007/s00101-025-01558-x.
2
Current Practice Regarding Bleeding Disorders of Unknown Cause in the Netherlands: A National Survey.荷兰关于不明原因出血性疾病的现行做法:一项全国性调查。
Haemophilia. 2025 Jul;31(4):752-760. doi: 10.1111/hae.70065. Epub 2025 May 27.
3
Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives.
不明原因出血性疾病:关于当前实践、知识差距及未来展望的图文综述
Res Pract Thromb Haemost. 2024 Nov 13;8(8):102625. doi: 10.1016/j.rpth.2024.102625. eCollection 2024 Nov.
4
Evaluating the impact of the self-BAT screening tool on patient outcomes: Results of the let's talk period project.评估自我BAT筛查工具对患者预后的影响:“畅所欲言”项目的结果
Haemophilia. 2024 Nov;30(6):1400-1405. doi: 10.1111/hae.15113. Epub 2024 Nov 15.
5
How to treat patients with bleeding disorder of unknown cause?如何治疗病因不明的出血性疾病患者?
Res Pract Thromb Haemost. 2024 Oct 9;8(7):102585. doi: 10.1016/j.rpth.2024.102585. eCollection 2024 Oct.
6
Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause.不明原因出血性疾病围手术期止血预防及结果
Res Pract Thromb Haemost. 2024 Sep 16;8(7):102572. doi: 10.1016/j.rpth.2024.102572. eCollection 2024 Oct.
7
Potential clinical applications of current and future oral forms of desmopressin (Review).当前及未来口服去氨加压素剂型的潜在临床应用(综述)
Exp Ther Med. 2024 May 29;28(2):303. doi: 10.3892/etm.2024.12592. eCollection 2024 Aug.
8
Bleeding assessment in a large cohort of patients with Osteogenesis Imperfecta.大量成骨不全症患者的出血评估。
Orphanet J Rare Dis. 2024 Feb 12;19(1):61. doi: 10.1186/s13023-024-03054-8.
9
Investigation of the effects of intranasal desmopressin on the bleeding of the patients during open septorhinoplasty: A randomized double-blind clinical trial.鼻腔去氨加压素对开放性鼻中隔成形术患者出血影响的研究:一项随机双盲临床试验。
Heliyon. 2023 Jul 1;9(7):e17855. doi: 10.1016/j.heliyon.2023.e17855. eCollection 2023 Jul.
10
Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time.对血小板功能分析仪关闭时间延长的出血患者进行多参数血小板功能分析。
Br J Haematol. 2022 Mar;196(6):1388-1400. doi: 10.1111/bjh.18003. Epub 2022 Jan 10.